Differential toxicity of carrier-bound methotrexate against tumor/bone marrow cells in vivo.
D000818:Animals; D001254:Astrocytoma / Q000188:drug therapy / Q000473:pathology*; D001853:Bone Marrow / Q000187:drug effects* / Q000254:growth & development; D001854:Bone Marrow Cells; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology*; D002460:Cell Line; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use* / Q000633:toxicity; D051379:Mice; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology*; D011107:Polylysine / Q000494:pharmacology; D012709:Serum Albumin / Q000494:pharmacology
D012709:Serum Albumin; D011107:Polylysine; D008727:Methotrexate